Center-Authored Papers

Filters: Author is Figlin, Robert A  [Clear All Filters]
2016
Bono P, Oudard S, Bodrogi I, Hutson TE, Escudier B, Machiels J-P, Thompson JA, Figlin RA, Ravaud A, Basaran M et al..  2016.  Outcomes in Patients With Metastatic Renal Cell Carcinoma Who Develop Everolimus-Related Hyperglycemia and Hypercholesterolemia: Combined Subgroup Analyses of the RECORD-1 and REACT Trials.. Clinical genitourinary cancer. Abstract
2015
McDermott DF, Cheng S-C, Signoretti S, Margolin KA, Clark JI, Sosman JA, Dutcher JP, Logan TF, Curti BD, Ernstoff MS et al..  2015.  The high-dose aldesleukin "select" trial: a trial to prospectively validate predictive models of response to treatment in patients with metastatic renal cell carcinoma.. Clinical cancer research : an official journal of the American Association for Cancer Research. 21(3):561-8. Abstract
2012
Motzer RJ, Hutson TE, Olsen MR, Hudes GR, Burke JM, Edenfield WJ, Wilding G, Agarwal N, Thompson JA, Cella D et al..  2012.  Randomized Phase II Trial of Sunitinib on an Intermittent Versus Continuous Dosing Schedule As First-Line Therapy for Advanced Renal Cell Carcinoma.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 30(12):1371-7. Abstract
2009
Motzer RJ, Agarwal N, Beard C, Bolger GB, Boston B, Carducci MA, Choueiri TK, Figlin RA, Fishman M, Hancock SL et al..  2009.  NCCN clinical practice guidelines in oncology: kidney cancer.. Journal of the National Comprehensive Cancer Network : JNCCN. 7(6):618-30.
Motzer RJ, Agarwal N, Beard C, Bolger GB, Boston B, Carducci MA, Choueiri TK, Figlin RA, Fishman M, Hancock SL et al..  2009.  NCCN clinical practice guidelines in oncology: testicular cancer.. Journal of the National Comprehensive Cancer Network : JNCCN. 7(6):672-93.
2008
Ettinger DS, Akerley W, Bepler G, Chang A, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Feigenberg SJ, Figlin RA et al..  2008.  Non-small cell lung cancer.. Journal of the National Comprehensive Cancer Network : JNCCN. 6(3):228-69.